<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a 54-year-old man with highly refractory <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet syndrome</z:e> associated with autoimmune multifocal organizing <z:hpo ids='HP_0002090'>pneumonia</z:hpo> and underlying <z:mpath ids='MPATH_341'>myelodysplastic disorder</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>His <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">lung disease</z:e> responded to oral <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>However, his <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">skin disease</z:e> and systemic symptoms followed a <z:hpo ids='HP_0011010'>chronic</z:hpo> course and responded only to very high doses of <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> and were refractory to a number of <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>-sparing agents </plain></SENT>
<SENT sid="3" pm="."><plain>He was ultimately treated with infliximab, resulting in remission of his cutaneous and systemic symptoms and successful tapering of his <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> dose </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequently, infliximab was replaced with adalimumab to achieve more sustained remission </plain></SENT>
<SENT sid="5" pm="."><plain>His pulmonary lesions have not recurred on this treatment </plain></SENT>
<SENT sid="6" pm="."><plain>His <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> followed a very <z:hpo ids='HP_0003677'>slowly progressive</z:hpo> course consistent with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>This case report demonstrates the effectiveness of treatment with monoclonal antibody specific for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNFalpha) in a patient with severe manifestations of <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet syndrome</z:e> refractory to other treatments </plain></SENT>
</text></document>